Azitra warned on NYSE American equity standard
Azitra, Inc. received a notice from NYSE American that it no longer meets the exchange’s listing standard requiring at least $4.0 million in stockholders’ equity for companies with losses in three of the four most recent fiscal years.
Rhea-AI Filing Summary
Azitra, Inc. received a notice from NYSE American that it no longer meets the exchange’s listing standard requiring at least $4.0 million in stockholders’ equity for companies with losses in three of the four most recent fiscal years. As of June 30, 2025, Azitra reported stockholders’ equity of $2.2 million and losses in three of its four most recent fiscal years ended December 31, 2024.
The company has until October 31, 2025 to submit a plan to regain compliance by April 1, 2027. If the plan is accepted, Azitra will undergo periodic reviews, and failure to execute or regain compliance by that date may lead to delisting proceedings. The letter does not immediately affect the listing or trading of Azitra’s common stock and does not change its SEC reporting obligations.
Positive
- None.
Negative
- NYSE American non-compliance and delisting risk: Azitra reported stockholders’ equity of $2.2 million as of June 30, 2025, below the NYSE American $4.0 million requirement for companies with multi-year losses, triggering a formal remediation process that could lead to delisting if the company fails to regain compliance by April 1, 2027.
Insights
NYSE American has flagged Azitra for low equity, creating medium-term delisting risk.
Azitra, Inc. fell below NYSE American’s stockholders’ equity requirement of $4.0 million, with equity of $2.2 million as of June 30, 2025 and losses in three of its four most recent fiscal years ended December 31, 2024. This triggers Section 1009 procedures, which are designed to address prolonged financial weakness rather than short-term volatility.
The company must submit a viable compliance plan by October 31, 2025, showing how it will meet continued listing standards by April 1, 2027. Acceptance of the plan would keep the stock listed during a monitoring period, but progress will be reviewed quarterly and failure to execute or meet targets can lead to delisting proceedings.
There is no immediate trading impact from the notice, and Azitra can appeal any staff delisting determination under Section 1010 and Part 12 of the Company Guide. Future disclosures about the submitted plan, NYSE American’s decision, and subsequent periodic reviews will clarify how the company addresses the equity shortfall and listing risk.
8-K Event Classification
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
Why did Azitra (AZTR) receive a non-compliance notice from NYSE American?
What listing standard is Azitra (AZTR) not meeting?
What deadlines has NYSE American set for Azitra (AZTR) to regain compliance?
Does the NYSE American notice immediately affect trading in Azitra (AZTR) stock?
What happens if Azitra (AZTR) does not submit an acceptable plan to NYSE American?
What if Azitra’s (AZTR) plan is accepted but it fails to regain compliance by April 1, 2027?
Can Azitra (AZTR) appeal a NYSE American delisting determination?
AI-generated analysis. How Rhea-AI works. Not financial advice.